Press Releases

Welcome to the Investing News Network's press release section, where you can stay informed with past and present announcements from our clients. Explore the latest stock news from mining, technology and life science companies and gain an investing edge by staying up to date with today's press releases.
Filters
Clear All Filters
Filter ✕

Date Range

Sector

Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia

Biotech Investing
Cardiex Limited (CDX:AU)

Results of Entitlement Offer

Biotech Investing

Radiopharm Theranostics Granted U.S. Food and Drug Administration Fast Track Designation for RAD101 Imaging in Brain Metastases

Biotech Investing
Radiopharm Theranostics (RAD:AU)

RAD Granted US FDA Fast Track for RAD101 Metastases Imaging

Biotech Investing
Cardiex Limited (CDX:AU)

Offer Booklet - Non-Renounceable Entitlement Offer

Biotech Investing

Radiopharm Theranostics Doses First Patient in Phase 1 'HEAT' Trial of 177Lu-RAD202 for Treatment of Advanced HER2-Positive Solid Tumors

Biotech Investing
Radiopharm Theranostics (RAD:AU)

RAD Doses 1st Patient in Therapeutic Trial of 177Lu-RAD202

Biotech Investing

Radiopharm Theranostics Reports Preclinical Lu177-B7H3-mAb Data Demonstrating Favourable Biodistribution and High Tumour Uptake

Biotech Investing
Cardiex Limited (CDX:AU)

Cardiex Receives TGA Approval for CONNEQT Pulse Device

Biotech Investing
Radiopharm Theranostics (RAD:AU)

RAD Reports Positive Preclinical Lu177-B7H3-mAb Data

Biotech Investing
Cardiex Limited (CDX:AU)

CDX May Investor Presentation

Biotech Investing
Cardiex Limited (CDX:AU)

Cardiex Completes Placement & Launches Entitlement Offer

Biotech Investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics Reports Results of 2025 Annual General Meeting of Shareholders

Biotech Investing
Cardiex Limited (CDX:AU)

Cardiex Limited (CDX:AU) has announced Trading Halt

Biotech Investing
Cardiol Therapeutics (CRDL:CA)

Cardiol Therapeutics to Webcast Virtual Annual General Meeting of Shareholders on May 28th at 4:30 p.m. EDT

Biotech Investing

ITM and Radiopharm Sign Supply Agreement for n.c.a. Lutetium-177

biotech investing

Accent Trial Data Demonstrates that Narmafotinib + Chemotherapy Combination Superior to Chemotherapy Alone

life science investing

Radiopharm Theranostics Accelerates 177Lu-RAD204 Phase 1 Dose Escalation Clinical Trial Based on Positive Recommendation from Data Safety and Monitoring Committee

biotech investing
Radiopharm Theranostics (RAD:AU)

Acceleration of RAD204 Phase 1 dose escalation trial

biotech investing

Radiopharm Theranostics to Participate in the D. Boral Capital Inaugural Global Conference

biotech investing

Latest News

More News

Outlook Reports

Resource
Tech
Life Science

Browse Companies

Resource
Tech
Life Science
MARKETS
COMMODITIES
CURRENCIES
×